Director, Worldwide Omnichannel Excellence Insights and Data at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Experience in co-leading implementation of data foundations for omnichannel marketing, with focus on third-party (NPP) data integration, governance, and optimization
Expertise in overseeing analytics and reporting resources, driving enterprise vision for unified, AI-powered measurement frameworks, advanced dashboards, and actionable insights
Knowledge of championing agentic AI adoption with technical rigor and business relevance
Ability to manage cross-functional partnerships and align analytics with global brand and commercial priorities
Leadership skills to mentor and develop high-performing analytics teams, fostering innovation and agile ways of working
Strong communication and influence skills to champion adoption of omnichannel measurement and AI-driven insights organization-wide

Responsibilities

Develop and execute a global strategy for third-party NPP data integration, standardization, and governance to support scalable and trusted omnichannel reporting and analytics
Define and socialize the measurement roadmap, prioritizing investments in AI, GenAI, and agentic analytics solutions for core and emerging markets
Provide thought leadership on leveraging AI, machine learning, and generative AI to transform commercial data, measurement, and reporting practices
Oversee the design and implementation of industry-leading data management frameworks for third-party NPP feeds, ensuring accuracy, quality, and consistency across all reporting and dashboards
Set and enforce standards for REQ definitions, data tagging (brand, indication, placement), and business rules to address data irregularities and drive trust in omnichannel insights delivery
Collaborate with global data and technology teams to operationalize weekly data refreshes and source-of-truth standards for all NPP and PP sources
Lead the development of unified, AI-powered omnichannel dashboards and measurement frameworks that deliver actionable insights to Commercial, Medical, Field, and Omnichannel teams
Design and enable interactive analytics platforms for campaign planning, optimization, and post-campaign reviews, embedding curated recommendations and real-time alerting
Guide development and deployment of agentic analytics solutions, including measurement & insights agents
Oversee the design and implementation of advanced analytics agents
Partner with IT, external partners, and brand teams to deliver rapid innovation, robust POCs, and scalable solutions across the portfolio
Mentor and develop a high-performing analytics team in the GCC, fostering continuous learning, agile ways of working, and a culture of innovation and impact
Build strong cross-functional relationships with Commercialization, Insights, Data Science, Brand, and Technology leaders to ensure tight alignment of analytics initiatives with strategic business objectives
Champion the adoption of omnichannel measurement and AI-driven insights across the organization

Skills

Omnichannel Marketing

Data Integration

Data Governance

Analytics

Reporting

GenAI

Agentic AI

Dashboards

NPP Data

Measurement Frameworks

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free